Evidence map›Paper›PMID 35054851›Full record

ArticleInternational journal of molecular sciences2022

The Dual Role of the β

Mikhail Melnikov, Vladimir Rogovskii, Anastasiya Sviridova, Anna Lopatina, Mikhail Pashenkov, Alexey Boyko

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mikhail MelnikovDepartment of Neuroimmunology, Federal Center of Brain research and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117513 Moscow, Russia.
Vladimir RogovskiiDepartment of Neuroimmunology, Federal Center of Brain research and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117513 Moscow, Russia.
Anastasiya SviridovaDepartment of Neuroimmunology, Federal Center of Brain research and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117513 Moscow, Russia.
Anna LopatinaDepartment of Neuroimmunology, Federal Center of Brain research and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117513 Moscow, Russia.
Mikhail PashenkovLaboratory of Clinical Immunology, National Research Center Institute of Immunology of the Federal Medical-Biological Agency of Russia, 115478 Moscow, Russia.
Alexey BoykoDepartment of Neuroimmunology, Federal Center of Brain research and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117513 Moscow, Russia.
Federal Medical-Biological Agency · RUPirogov Russian National Research Medical University · RU

Funding

Ministry of Health of the Russian Federation. АААА-А19-119042590021-0
6 · The paper itself

Abstract

Norepinephrine is a neurotransmitter that also has an immunomodulatory effect and is involved in multiple sclerosis (MS) pathogenesis. This study aimed to clarify the role of the β

Indexed as

AdultCase-Control StudiesCD4-Positive T-LymphocytesCytokinesEpinephrineFemaleHumansInterferon-gammaInterleukin-17MaleMethoxyhydroxyphenylglycolMultiple SclerosisNorepinephrineReceptors, Adrenergic, beta-2T-LymphocytesCytokinesEpinephrineInterferon-gammaInterleukin-17MethoxyhydroxyphenylglycolNorepinephrineReceptors, Adrenergic, beta-2multiple sclerosisnorepinephrineTh1 and Th17 cellsβ2-adrenoreceptor

Identifiers

PMID35054851
PMCPMC8775997
OpenAlexW4206247857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.